up and up nighttime sleep aid
- Product NDC
- 11673-171
- 11-digit product format
- 116730171
- Labeler code
- 11673
- Product ID
- 11673-171_7df6367d-7e14-41c1-8c50-d3970ecf4134
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Doxylamine succinate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Target Corporation
- Application
- ANDA040167
- Marketing category
- ANDA
- Marketing start
- 2022-02-04
- Substance
- DOXYLAMINE SUCCINATE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Antihistamine [EPC], Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- up and up nighttime sleep aid
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXYLAMINE SUCCINATE | 25 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | V9BI9B5YI2 |
| Rxcui | 1101446 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 11673-171-01 | up and up nighttime sleep aid | 96 in 1 BOTTLE | TABLET | 96 | | 3 |
| 11673-171-01 | up and up nighttime sleep aid | 1 in 1 CARTON | TABLET | 1 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 11673-171 | UP AND UP NIGHTTIME SLEEP AID (DOXYLAMINE SUCCINATE) TABLET [TARGET CORPORATION] | 3 | Current NDC, Legacy NDC, 2 package rows | 20250406_24a0144d-cbfc-4d2f-873d-86adfa0468ca.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 11673-171-01 | 11673017101 | 1 BOTTLE in 1 CARTON (11673-171-01) / 96 TABLET in 1 BOTTLE | 1 bottle | 2022-02-04 | 0000-00-00 | No | No | Current |